Cite
HARVARD Citation
McDermott, D. et al. (2018). Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nature medicine. p. 1941. [Online].